News
Balaxi Pharmaceuticals consolidated net profit declines 92.94% in the March 2026 quarter
29-May-2026 | 17:25
Sales decline 7.29% to Rs 70.71 crore
Net profit of Balaxi Pharmaceuticals declined 92.94% to Rs 0.61 crore in the quarter ended March 2026 as against Rs 8.64 crore during the previous quarter ended March 2025. Sales declined 7.29% to Rs 70.71 crore in the quarter ended March 2026 as against Rs 76.27 crore during the previous quarter ended March 2025.
For the full year,net profit declined 94.34% to Rs 1.42 crore in the year ended March 2026 as against Rs 25.07 crore during the previous year ended March 2025. Sales declined 7.65% to Rs 270.17 crore in the year ended March 2026 as against Rs 292.56 crore during the previous year ended March 2025.
| Particulars | Quarter Ended | Year Ended | ||||
| Mar. 2026 | Mar. 2025 | % Var. | Mar. 2026 | Mar. 2025 | % Var. | |
| Sales | 70.71 | 76.27 | -7 | 270.17 | 292.56 | -8 |
| OPM % | 0.17 | 16.45 | - | 3.16 | 12.72 | - |
| PBDT | 2.05 | 10.12 | -80 | 7.45 | 30.56 | -76 |
| PBT | 1.40 | 9.66 | -86 | 5.29 | 28.67 | -82 |
| NP | 0.61 | 8.64 | -93 | 1.42 | 25.07 | -94 |
Powered by Capital Market - Live News